ZyVersa Therapeutics Announces Changes to ZyVersa's Board of Directors
WESTON, Fla., May 19, 2023 -- ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases... | May 19, 2023
Source: marketscreener.com